BioStem Technologies, Inc. (BSEM) Net margin 2024–2025
BioStem Technologies, Inc. (BSEM) net profit margin by fiscal year — reported net income divided by reported revenue.
-13.9%FY2025 · since FY2024: 44.5% → -13.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -13.9% | -58.4 pp |
| FY2024 | 44.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BSEM financial trends
BSEM RevenueBSEM Net incomeBSEM Gross profitBSEM Gross marginBSEM Operating incomeBSEM Operating marginBSEM Operating cash flowBSEM Free cash flowBSEM Capital expendituresBSEM Return on equityBSEM Stock buybacksBSEM Dividends paidBSEM Total assetsBSEM Total liabilitiesBSEM Shareholders’ equityBSEM overview →